Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T20789 |
S-23
(S)-3-(4-chloro-3-fluorophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methylpropanamide,S23 |
Androgen Receptor | Endocrinology/Hormones |
S-23 ((S)-3-(4-chloro-3-fluorophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methylpropanamide) 是口服选择性雄激素受体调节剂(Ki:1.7 nM)。它能够诱导 CV-1 细胞雄激素受体介导的转录激活,提高去势大鼠前列腺、精囊和肛提肌重量。 | |||
T8457 |
NPS2390
|
GluR | Neuroscience |
NPS2390 是钙敏感受体抑制剂,也是 mGluR1 和 mGluR5 的非竞争性拮抗剂。 | |||
T60002 |
DC-S239
|
Histone Methyltransferase | Chromatin/Epigenetic |
DC-S239 (DC-S239) 是一种选择性的组蛋白甲基转移酶 SETD7 抑制剂 (IC50 = 4.59 μM),具有抗癌活性。 | |||
T30176 |
ASS234
AS S234,AS-S234 |
||
ASS234 is a multi-target propylamine used in the treatment of Alzheimer's disease. | |||
T70345 | JAS239 | ||
JAS239 is a novel carbocyanine dye that binds and competitively inhibits choline kinase (ChoK) intracellularly. JAS239 attenuated choline phosphorylation and viability in a panel of human breast cancer cell lines. Antibody blockade prevented cellular retention of JAS239 indicating direct interaction with ChoKα independent of the choline transporters and catabolic choline pathways. In mice bearing orthotopic MCF7 breast xenografts, optical imaging with JAS239 distinguished tumors overexpressing C... | |||
T82158 |
Human IgG1 (S239D/I332E) kappa, Isotype Control
|
||
HumanIgG1(S239D/I332E) kappa, Isotype Control为一种人源-鼠源嵌合型单克隆抗体,作为HumanIgG1(S239D/I332E)κ抗体之同型对照物。 | |||
T62532 |
MRS2395
|
||
MRS2395 是一种二戊酰衍生物,是一种 P2Y12 受体的有效拮抗剂。MRS2395 抑制 ADP 诱导的血小板活化 (Ki: 3.6 μM)。MRS2395 在 PGE1 存在下,对大鼠血小板中 ADP 诱导的 cAMP 具有抑制作用 (IC50: 7 μM)。MRS2395 增强血小板致密颗粒释放以响应 TRAP-6。 | |||
T34473 |
S2366 HCl
S2366 hydrochloride,S 2366,S-2366,S2366 |
||
S 2366 is a chromogenic substrate for Factor XI in plasma. | |||
T25084 |
AM-TS23
AM TS23 |
||
AM-TS23 is used as a DNA polymerase lambda and beta inhibitor. | |||
T26171 |
S23757
S-23757,S 23757 |
||
S23757 is an imidazoline 1 receptor (I1R) selective ligand. | |||
T68613 | DC-S238 | ||
DC-S238 is a potent and selective histone methyltransferase SET7 inhibitor. |